Please login to the form below

Not currently logged in
Email:
Password:

cancer drug funding

This page shows the latest cancer drug funding news and features for those working in and with pharma, biotech and healthcare.

Cancer charities criticise NICE's 'last-century methodology'

Cancer charities criticise NICE's 'last-century methodology'

Group of 15 claims many new prostate cancer drugs will now ‘struggle to gain approval’.  . ... cancer drugs funding,” said the charity's chief executive Mark Flanagan.

Latest news

  • England's Cancer Drugs Fund: Fixing a broken system England's Cancer Drugs Fund: Fixing a broken system

    Meanwhile, shortly after the de-listing announcement, the Anglo-Swedish firm AstraZeneca said it would not even bother putting its newly approved ovarian cancer drug Lynparza (olaparib) up for funding via ... sustainable solution to cancer drug access

  • Decision to withdraw Jevtana in England ‘flawed’ Decision to withdraw Jevtana in England ‘flawed’

    Urologists and oncologists attack NHS England’s de-listing of Sanofi’s drug. A UK charity has denounced NHS England's decision to withdraw a new prostate cancer drug from its ... It is currently the only treatment for hormone resistant advanced

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Engaging the digital healthcare professional Engaging the digital healthcare professional

    When NICE, the UK policymaker for health spending, rejected Pfizer’s breast cancer drug palbociclib for routine funding on the NHS in February, it tweeted the news and invited comments on ... It was also shared by a student midwife who tweeted to

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics